Reznik Y - Search Results

1

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial.

Aronson R, Reznik Y, Conget I, Castañeda JA, Runzis S, Lee SW, Cohen O; OpT2mise Study Group. Aronson R, et al. Among authors: reznik y. Diabetes Obes Metab. 2016 May;18(5):500-7. doi: 10.1111/dom.12642. Epub 2016 Mar 22. Diabetes Obes Metab. 2016. PMID: 26854123 Free PMC article. Clinical Trial.

2

Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure.

Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, Fradin S, Reznik Y. Berthe E, et al. Among authors: reznik y. Horm Metab Res. 2007 Mar;39(3):224-9. doi: 10.1055/s-2007-970423. Horm Metab Res. 2007. PMID: 17373639 Clinical Trial.

3

Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes.

Reznik Y. Reznik Y. Diabetes Metab. 2010 Dec;36(6 Pt 1):415-21. doi: 10.1016/j.diabet.2010.08.002. Diabetes Metab. 2010. PMID: 20888280 Review.

4

Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use.

Joubert M, Reznik Y. Joubert M, et al. Among authors: reznik y. Diabetes Res Clin Pract. 2012 Jun;96(3):294-305. doi: 10.1016/j.diabres.2011.12.010. Epub 2011 Dec 28. Diabetes Res Clin Pract. 2012. PMID: 22209014 Review.

5

Management of hyperglycaemia in Cushing's disease: experts' proposals on the use of pasireotide.

Reznik Y, Bertherat J, Borson-Chazot F, Brue T, Chanson P, Cortet-Rudelli C, Delemer B, Tabarin A, Bisot-Locard S, Vergès B. Reznik Y, et al. Diabetes Metab. 2013 Feb;39(1):34-41. doi: 10.1016/j.diabet.2012.10.005. Epub 2012 Dec 8. Diabetes Metab. 2013. PMID: 23228667 Review.

6

Treating diabetes with islet transplantation: lessons from the past decade in Lille.

Vantyghem MC, Defrance F, Quintin D, Leroy C, Raverdi V, Prévost G, Caiazzo R, Kerr-Conte J, Glowacki F, Hazzan M, Noel C, Pattou F, Diamenord AS, Bresson R, Bourdelle-Hego MF, Cazaubiel M, Cordonnier M, Delefosse D, Dorey F, Fayard A, Fermon C, Fontaine P, Gillot C, Haye S, Le Guillou AC, Karrouz W, Lemaire C, Lepeut M, Leroy R, Mycinski B, Parent E, Siame C, Sterkers A, Torres F, Verier-Mine O, Verlet E; G4 working groups; Desailloud R, Dürrbach A, Godin M, Lalau JD, Lukas-Croisier C, Thervet E, Toupance O, Reznik Y, Westeel PF. Vantyghem MC, et al. Among authors: reznik y. Diabetes Metab. 2014 Apr;40(2):108-19. doi: 10.1016/j.diabet.2013.10.003. Epub 2014 Feb 6. Diabetes Metab. 2014. PMID: 24507950 Review.

7

Reductions in A1C with pump therapy in type 2 diabetes are independent of C-peptide and anti-glutamic acid decarboxylase antibody concentrations.

Reznik Y, Huang S; OpT2mise Study Group. Reznik Y, et al. Diabetes Technol Ther. 2014 Nov;16(11):816-8. doi: 10.1089/dia.2014.0261. Epub 2014 Sep 5. Diabetes Technol Ther. 2014. PMID: 25192407 Free PMC article. No abstract available.

8

One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.

Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, Young J, Mathivon L, Travert F, Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M, Gautier J, Vigouroux C. Vatier C, et al. Among authors: reznik y. Diabetes Obes Metab. 2016 Jul;18(7):693-7. doi: 10.1111/dom.12606. Epub 2016 Jan 12. Diabetes Obes Metab. 2016. PMID: 26584826

9

Cost-effectiveness of continuous subcutaneous insulin infusion in people with type 2 diabetes in the Netherlands.

Roze S, Duteil E, Smith-Palmer J, de Portu S, Valentine W, de Brouwer BF, Reznik Y, de Valk HW. Roze S, et al. Among authors: reznik y. J Med Econ. 2016 Aug;19(8):742-9. doi: 10.3111/13696998.2016.1167695. Epub 2016 Apr 5. J Med Econ. 2016. PMID: 26985982 Free article.

10

Factors affecting the benefit of insulin dose intensification in people with Type 2 diabetes: an analysis from the OpT2mise randomized trial.

Schütz-Fuhrmann I, Castañeda J, Reznik Y, Aronson R, Conget I, Liabat S, Runzis S, de Portu S, Cohen O. Schütz-Fuhrmann I, et al. Among authors: reznik y. Diabet Med. 2017 Feb;34(2):291-292. doi: 10.1111/dme.13279. Diabet Med. 2017. PMID: 27770589 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page